INSTITUTION'S PROFILE
Molecular Virology Group, Department of Biomedicine, Basel, Switzerland.
Publications (1)
Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho.
Journal: HIV medicine
Publication date: 2023
Journal: HIV medicine
Publication Year: 2023